Sabanayagam Charumathi, Yip WanFen, Ting Daniel S W, Tan Gavin, Wong Tien Y
a Singapore Eye Research Institute, Singapore National Eye Centre , Singapore.
b Center for Quantitative Medicine, Duke-NUS Medical School , Singapore.
Ophthalmic Epidemiol. 2016 Aug;23(4):209-22. doi: 10.1080/09286586.2016.1193618. Epub 2016 Jun 29.
Diabetes is a major public health problem affecting 415 million people worldwide. With the increasing prevalence of diabetes, diabetic retinopathy (DR) is emerging as the leading cause of avoidable blindness worldwide.
We reviewed previous and recent literature to provide an overview of emerging trends on the burden, epidemiology, risk factors, and prevention of DR.
First, there is clear evidence of a global increase in the prevalence of diabetes. Second, there is a decline in the incidence of blindness due to DR, particularly in developed countries. Third, diabetic macular edema (DME) rather than proliferative diabetic retinopathy (PDR) is the increasingly common cause of visual impairment. Fourth, DR awareness remains patchy and low in most populations. Fifth, hyperglycemia remains the most consistent risk factor for DR in type 1 diabetes across different studies and populations. Sixth, in contrast, blood pressure is an important risk factor for DR in type 2 diabetes. Seventh, the relationship between dyslipidemia and DR remains unclear, with inconsistent results from different studies and trials. Eighth, the utility of predictive models incorporating multiple risk factors for assessing DR risk requires evaluation. Ninth, photographic screening of DR using tele-ophthalmology platforms is increasingly recognized as being feasible and cost-effective. Finally, DR prevention in low-resource settings cannot follow models developed in high-resource countries and requires different strategies.
The ten trends we observed in the current review may guide planning of public healthcare strategies for the management of DR and prevention of blindness.
糖尿病是一个重大的公共卫生问题,全球有4.15亿人受其影响。随着糖尿病患病率的不断上升,糖尿病视网膜病变(DR)正成为全球可避免失明的主要原因。
我们回顾了既往及近期的文献,以概述DR在负担、流行病学、危险因素及预防方面的新趋势。
首先,有明确证据表明全球糖尿病患病率在上升。其次,因DR导致的失明发病率有所下降,尤其是在发达国家。第三,糖尿病性黄斑水肿(DME)而非增殖性糖尿病视网膜病变(PDR)日益成为视力损害的常见原因。第四,在大多数人群中,对DR的认知仍然零散且水平较低。第五,在不同研究和人群中,高血糖仍然是1型糖尿病患者发生DR最一致的危险因素。第六,相比之下,血压是2型糖尿病患者发生DR的重要危险因素。第七,血脂异常与DR之间的关系仍不明确,不同研究和试验结果不一致。第八,纳入多个危险因素的预测模型在评估DR风险方面的效用需要评估。第九,使用远程眼科平台对DR进行摄影筛查越来越被认为是可行且具有成本效益的。最后,资源匮乏地区的DR预防不能照搬高资源国家制定的模式,需要采取不同的策略。
我们在本次综述中观察到的这十个趋势可能会为DR管理和失明预防的公共卫生策略规划提供指导。